Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Uncover the advantages of investing in gold versus savings accounts. Learn which option suits your financial goals better.
23,656 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Analysts outline a path to higher earnings for Southwest in 2026, but fuel costs and customer fees remain key risks. ...
Bank of America has agreed to a $72.5 million settlement in a high-profile Epstein-related civil case, avoiding admis...
A high-profile sale sparks a crypto market reshuffle. This morning minute breaks down what Saylor's move means for Bi...
Could Apple defy a mid-year lull and spark a second-half rally in 2026? This article breaks down the catalysts, risks...
A single ETF provides regulated exposure to U.S. cannabis operators by using swaps to bypass direct holdings. The tra...
With $1,000 in hand, you can explore high-growth artificial intelligence moonshots. This guide breaks down two potent...
Sprinklr has seen a steep slide, slipping about 40% over the past year. A large fund recently sold close to $3 millio...
A Biel note argues that biel: salesforce’s transaction data creates a durable moat for Salesforce, tying revenue to a...
A sharp divergence in the online brokerage space emerges in 2026 as Robinhood declines while Interactive Brokers gain...
Rocket Lab stands as the only public space stock with a direct line to actual launches and defense demand, even as Sp...
SpaceX hit the public markets with an IPO price of $135 per share, signaling a game-changing moment for growth invest...